Awanui Group has launched Awanui Horizon, a dedicated innovation, research and test development programme designed to accelerate the development of new diagnostic solutions, research partnerships and healthcare innovations that improve patient outcomes across Aotearoa New Zealand.
As New Zealand’s largest community pathology laboratory network, Awanui serves clinicians, healthcare providers and patients nationwide. Horizon has been established to provide a structured pathway for identifying, evaluating and scaling opportunities that strengthen pathology services and support the future of healthcare delivery.
The initiative brings together innovation, research and test development activities under a single framework, enabling clinicians, researchers, industry partners and Awanui teams to advance ideas with the potential to deliver meaningful clinical and operational impact.
“Awanui Horizon creates a structured way for great ideas to become real-world outcomes,” said Heather Phillips, Chief Strategy Officer at Awanui Group.
“Horizon gives innovation a home, ensuring opportunities are assessed consistently, supported rigorously and aligned to the strategic priorities of the organisation. Our goal is to connect science, research, technology and clinical expertise in ways that improve healthcare outcomes for New Zealanders.”
Supporting better patient outcomes
The launch comes at a time when healthcare systems are increasingly focused on earlier diagnosis, improved patient access and more efficient delivery of services.
Through Horizon, Awanui will focus on opportunities that:
- Advance clinically validated diagnostic tests that address unmet healthcare needs.
- Improve patient experiences through faster results and less invasive sampling approaches.
- Support healthcare innovation through research, collaboration and evidence-based development.
- Deliver measurable value through improved efficiency, new service opportunities and strengthened sector capability.
Three core areas of focus
Awanui Horizon will operate across three key streams:
New Tests and Diagnostic Products
Development of innovative diagnostic tests, sample collection methods and testing solutions that help address emerging healthcare needs.
Research and Strategic Partnerships
Collaboration with research institutions, healthcare providers, universities and industry partners to support scientific discovery, innovation and research-led healthcare improvements.
New Processes, Systems and Technology
Identification and development of improved workflows, technologies and customer experiences that enhance service delivery, quality and operational performance.
Building the future of pathology
Awanui believes that innovation is essential to meeting the changing needs of patients, healthcare providers and the wider health sector.
By creating a dedicated platform for innovation, Horizon aims to accelerate the translation of ideas into practical solutions that improve diagnostic services and support better healthcare outcomes across Aotearoa New Zealand.
Researchers, clinicians, healthcare organisations, industry partners and Awanui team members with ideas, technologies or opportunities that could improve pathology services are encouraged to connect with the Horizon team through horizon@awanuigroup.co.nz.